View Future GrowthElixirr International 過去の業績過去 基準チェック /46Elixirr Internationalは、平均年間20%の収益成長を遂げていますが、 Professional Services業界の収益は、年間 成長しています。収益は、平均年間12.3% 26.8%収益成長率で 成長しています。 Elixirr Internationalの自己資本利益率は13.8%であり、純利益率は13.2%です。主要情報19.96%収益成長率18.82%EPS成長率Professional Services 業界の成長10.99%収益成長率26.80%株主資本利益率13.82%ネット・マージン13.17%前回の決算情報31 Dec 2025最近の業績更新お知らせ • Jan 22+ 2 more updatesElixirr International plc to Report Fiscal Year 2025 Results on Apr 20, 2026Elixirr International plc announced that they will report fiscal year 2025 results at 8:00 AM, GMT Standard Time on Apr 20, 2026お知らせ • Jul 14Elixirr International plc to Report First Half, 2025 Results on Sep 22, 2025Elixirr International plc announced that they will report first half, 2025 results on Sep 22, 2025お知らせ • Mar 11Elixirr International plc to Report Fiscal Year 2024 Results on Apr 28, 2025Elixirr International plc announced that they will report fiscal year 2024 results at 8:00 AM, GMT Standard Time on Apr 28, 2025お知らせ • Apr 08Elixirr International plc to Report Fiscal Year 2023 Results on Apr 22, 2024Elixirr International plc announced that they will report fiscal year 2023 results on Apr 22, 2024すべての更新を表示Recent updatesお知らせ • Apr 20Elixirr International plc Recommends Final Dividend for Fiscal Year 2025, Payable on August 2026Elixirr International plc announced the Board recommend a final dividend for Fiscal Year 25 of 15.0 pence per Ordinary Share, payable in August 2026 making a total dividend of 22.6 pence for the Fiscal Year 25 financial year, a 27% increase on the Fiscal Year 24 dividend. The final dividend will be recommended to shareholders at the AGM in June 2026. The Fiscal Year 25 final dividend will have a total cash cost of £7.5 million.お知らせ • Feb 03Elixirr International plc (LSE:ELIX) acquired Kvadrant Consulting A/S for approximately DKK 150 million.Elixirr International plc (LSE:ELIX) acquired Kvadrant Consulting A/S for approximately DKK 150 million on January 30, 2026. The maximum consideration payable under the terms of the Acquisition is DKK154.8 million, consisting of Initial cash consideration of DKK78.8 million, subject to customary working capital adjustments and holdbacks at completion, which has been settled from the Group's operating cashflow and revolving credit facility, DKK28.8 million to be settled through the issuance of 415,213 new ordinary shares, deferred consideration of up to DKK47.3 million (GBP£5.5 million), payable in cash or Ordinary Shares at the Company's discretion, which is contingent on Kvadrant achieving EBITDA margin and revenue targets in periods up to December 31, 2028. Elixirr International plc (LSE:ELIX) completed the acquisition of Kvadrant Consulting A/S on January 30, 2026.お知らせ • Jan 22+ 2 more updatesElixirr International plc to Report Fiscal Year 2025 Results on Apr 20, 2026Elixirr International plc announced that they will report fiscal year 2025 results at 8:00 AM, GMT Standard Time on Apr 20, 2026お知らせ • Sep 22+ 1 more updateElixirr International plc (LSE:ELIX) completed the acquisition of TRC Advisory.Elixirr International plc (LSE:ELIX) acquired TRC Advisory for approximately $130 million on September 19, 2025. A cash consideration of $41 million and common equity of Elixirr International plc having a value of $16 million will be issued for common equity of TRC Advisory. Elixirr International plc will pay an earnout/contingent payment of $24 million cash and of $8 million common equity. A further deferred performance-based payment of up to $36 million, payable over three years (2026, 2027 and 2028) in three instalments, either in cash or through the allotment and issue of further new Ordinary Shares. As part of consideration, $125 million is paid towards common equity of TRC Advisory. Elixirr has agreed the option of a US$20.25 million Loan and an increase in its Facility with NatWest from £45 million to £65 million. For the period ending December 31, 2024, TRC Advisory reported total revenue of $28.8 million and EBITDA of $13.5 million. Tim Romberger (Founder & Managing Director), Cyrus Patel (Managing Director), Mark Skoskiewicz (Director), Garan Geist (Director), Mason Kissell (Managing Director) and Hemal Vyas (Director) will, following Completion, become Partners in Elixirr. Employee retention has been considered as part of the consideration structure for the Acquisition in order to mitigate this risk. Elixirr International plc (LSE:ELIX) completed the acquisition of TRC Advisory on September 19, 2025.お知らせ • Jul 14Elixirr International plc to Report First Half, 2025 Results on Sep 22, 2025Elixirr International plc announced that they will report first half, 2025 results on Sep 22, 2025お知らせ • May 30Elixirr International plc, Annual General Meeting, Jun 24, 2025Elixirr International plc, Annual General Meeting, Jun 24, 2025. Location: lainston house, woodman lane, sparsholt, winchester, so21 2lt, United Kingdomお知らせ • Mar 11Elixirr International plc to Report Fiscal Year 2024 Results on Apr 28, 2025Elixirr International plc announced that they will report fiscal year 2024 results at 8:00 AM, GMT Standard Time on Apr 28, 2025お知らせ • Feb 18Elixirr International plc Provides Earnings Guidance for the Financial Year Ended 31 December 2024Elixirr International plc provided earnings guidance for the financial year ended 31 December 2024. For the year, the company results are expected to be above market expectations with: Revenue greater than £111 million, above the guidance range of £108 million to £111 million.お知らせ • Dec 20Elixirr International plc Declares Interim Dividend for the Year Ending 31 December 2024, Payable on January 24, 2025The Board of Elixirr International plc confirmed the amount and timing of its interim dividend for the year ending 31 December 2024. In accordance with the Company's dividend policy announced on 8 January 2024, the Company will continue to declare two dividends per year, with an interim dividend paid after the end of the year and a final dividend payable in August. The Company is declaring an interim dividend of 6.3 pence per Ordinary Share. The Dividend will be payable to Shareholders on the register as at 24 January 2025 and has an associated ex-dividend date of 23 January 2025. The Dividend of approximately £3.0 million in total will be paid to Shareholders on 17 February 2025 and funded from the Company's operating cash flow.お知らせ • Dec 11Elixirr International plc Announces Changes to Chief Financial Officer, with Effect from 1 January 2025Elixirr International plc announced that Graham Busby, Co-Founder & Chief Financial Officer, will be appointed as Deputy Chief Executive Officer of Elixirr with effect from 1 January 2025. In this role, Graham will continue to be responsible for the Group's acquisition strategy which he has led since 2020. Nick Willott, Finance Director and Company Secretary, will be appointed as Chief Financial Officer with effect from 1 January 2025 and is expected to join the Board of Elixirr following completion of requisite due diligence procedures.お知らせ • Dec 10Elixirr International plc Announces Management ChangesElixirr International plc announced the following changes to its Board of Directors. Graham Busby, Co-Founder & Chief Financial Officer, will be appointed as Deputy Chief Executive Officer of Elixirr with effect from 1 January 2025. In this role, Graham will continue to be responsible for the Group's acquisition strategy which he has led since 2020. Stephen Newton will continue as Chief Executive Officer. The Company also announces that Ian Ferguson, Co-Founder & Director, will step down from the Board on 1 January 2025, becoming a Board Advisor.お知らせ • Oct 26+ 1 more updateElixirr International plc has completed a Follow-on Equity Offering in the amount of £24.999995 million.Elixirr International plc has completed a Follow-on Equity Offering in the amount of £24.999995 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 3,846,153 Price\Range: £6.5 Transaction Features: Subsequent Direct Listingお知らせ • Sep 23Elixirr International plc Reiterates Earnings Guidance for the Year 2024Elixirr International plc reiterated earnings guidance for the year 2024. For the year, the company expects revenue within the guidance range of £104 million -110 million and profitability remains strong.お知らせ • Jun 02Elixirr International plc, Annual General Meeting, Jun 25, 2024Elixirr International plc, Annual General Meeting, Jun 25, 2024. Location: lainston house, woodman lane, sparsholt, winchester so21 2lt, United Kingdomお知らせ • Apr 24+ 1 more updateElixirr International plc Provides Earnings Guidance for the Year 2024Elixirr International plc provided earnings guidance for the year 2024. The company expects this momentum to continue over the rest of the year and, therefore, are targeting year 2024 revenue in the range of £104 million - £110 million.お知らせ • Apr 08Elixirr International plc to Report Fiscal Year 2023 Results on Apr 22, 2024Elixirr International plc announced that they will report fiscal year 2023 results on Apr 22, 2024お知らせ • Jan 08+ 1 more updateElixirr International plc Provides Earnings Guidance for the Year Ended 31 December 2023Elixirr International plc provided earnings guidance for the year ended 31 December 2023. Subject to audit, FY23 results are expected to be in line with market expectations with: Revenue within the guidance range of £85 million - £90 million.お知らせ • Dec 12Elixirr International plc (AIM:ELIX) acquired Insigniam $18.5 million.Elixirr International plc (AIM:ELIX) acquired Insigniam for $18.5 million on December 11, 2023. As part of the acquisition, Elixirr welcomes four new partners into the team: Insigniam Founding Partners Shideh Bina and Nathan Rosenberg, as well as Katerin Le Folcalvez and Jennifer Zimmer. Elixirr International plc (AIM:ELIX) completed the acquisition of Insigniam on December 11, 2023.お知らせ • Sep 19+ 1 more updateElixirr International plc (AIM:ELIX) acquired Responsum, Inc. for $6.6 million.Elixirr International plc (AIM:ELIX) acquired Responsum, Inc. for $6.6 million on September 18, 2023. The consideration consists of Potential earn-out payments of up to $1.0 million in cash and consideration of $3.4 million to be settled through the issue in September 2023 of 505,196 Elixirr International plc Ordinary shares. The Ordinary Shares purchased pursuant to the Acquisition will be subject to restrictions on sale for a total period of up to 4 years. The sellers have also agreed 3-year restrictive covenants. Responsum was co-founded by Steve Steinberg (CEO) and Adam Hofmann (Chief Marketing Officer). Steve will continue to lead the business following the Acquisition. Elixirr International plc (AIM:ELIX) completed the acquisition of Responsum, Inc. on September 18, 2023.お知らせ • May 19+ 1 more updateElixirr International plc, Annual General Meeting, Jun 13, 2023Elixirr International plc, Annual General Meeting, Jun 13, 2023, at 08:00 Coordinated Universal Time. Location: 00 Cheapside, EC2V 6DT London United Kingdom収支内訳Elixirr International の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史OTCPK:ELXX.F 収益、費用、利益 ( )GBP Millions日付収益収益G+A経費研究開発費31 Dec 251502018030 Sep 251401916030 Jun 251301913031 Mar 251211712031 Dec 241111611030 Sep 241041710030 Jun 24971810031 Mar 2492189031 Dec 2386179030 Sep 2383168030 Jun 2380148031 Mar 2376137031 Dec 2272137030 Sep 2266126030 Jun 2260126031 Mar 2255115031 Dec 2151105030 Sep 214695030 Jun 214184031 Mar 213664031 Dec 203054031 Dec 1926240質の高い収益: ELXX.Fは 高品質の収益 を持っています。利益率の向上: ELXX.Fの現在の純利益率 (13.2%)は、昨年(14.7%)よりも低くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: ELXX.Fの収益は過去 5 年間で年間20%増加しました。成長の加速: ELXX.Fの過去 1 年間の収益成長率 ( 20.3% ) は、5 年間の平均 ( 年間20%を上回っています。収益対業界: ELXX.Fの過去 1 年間の収益成長率 ( 20.3% ) はProfessional Services業界8.7%を上回りました。株主資本利益率高いROE: ELXX.Fの 自己資本利益率 ( 13.8% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YCommercial-services 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/23 20:58終値2026/04/20 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Elixirr International plc 4 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。6 アナリスト機関James FletcherBerenbergGuy HewettCavendishMichael DonnellyInvestec Bank plc (UK)3 その他のアナリストを表示
お知らせ • Jan 22+ 2 more updatesElixirr International plc to Report Fiscal Year 2025 Results on Apr 20, 2026Elixirr International plc announced that they will report fiscal year 2025 results at 8:00 AM, GMT Standard Time on Apr 20, 2026
お知らせ • Jul 14Elixirr International plc to Report First Half, 2025 Results on Sep 22, 2025Elixirr International plc announced that they will report first half, 2025 results on Sep 22, 2025
お知らせ • Mar 11Elixirr International plc to Report Fiscal Year 2024 Results on Apr 28, 2025Elixirr International plc announced that they will report fiscal year 2024 results at 8:00 AM, GMT Standard Time on Apr 28, 2025
お知らせ • Apr 08Elixirr International plc to Report Fiscal Year 2023 Results on Apr 22, 2024Elixirr International plc announced that they will report fiscal year 2023 results on Apr 22, 2024
お知らせ • Apr 20Elixirr International plc Recommends Final Dividend for Fiscal Year 2025, Payable on August 2026Elixirr International plc announced the Board recommend a final dividend for Fiscal Year 25 of 15.0 pence per Ordinary Share, payable in August 2026 making a total dividend of 22.6 pence for the Fiscal Year 25 financial year, a 27% increase on the Fiscal Year 24 dividend. The final dividend will be recommended to shareholders at the AGM in June 2026. The Fiscal Year 25 final dividend will have a total cash cost of £7.5 million.
お知らせ • Feb 03Elixirr International plc (LSE:ELIX) acquired Kvadrant Consulting A/S for approximately DKK 150 million.Elixirr International plc (LSE:ELIX) acquired Kvadrant Consulting A/S for approximately DKK 150 million on January 30, 2026. The maximum consideration payable under the terms of the Acquisition is DKK154.8 million, consisting of Initial cash consideration of DKK78.8 million, subject to customary working capital adjustments and holdbacks at completion, which has been settled from the Group's operating cashflow and revolving credit facility, DKK28.8 million to be settled through the issuance of 415,213 new ordinary shares, deferred consideration of up to DKK47.3 million (GBP£5.5 million), payable in cash or Ordinary Shares at the Company's discretion, which is contingent on Kvadrant achieving EBITDA margin and revenue targets in periods up to December 31, 2028. Elixirr International plc (LSE:ELIX) completed the acquisition of Kvadrant Consulting A/S on January 30, 2026.
お知らせ • Jan 22+ 2 more updatesElixirr International plc to Report Fiscal Year 2025 Results on Apr 20, 2026Elixirr International plc announced that they will report fiscal year 2025 results at 8:00 AM, GMT Standard Time on Apr 20, 2026
お知らせ • Sep 22+ 1 more updateElixirr International plc (LSE:ELIX) completed the acquisition of TRC Advisory.Elixirr International plc (LSE:ELIX) acquired TRC Advisory for approximately $130 million on September 19, 2025. A cash consideration of $41 million and common equity of Elixirr International plc having a value of $16 million will be issued for common equity of TRC Advisory. Elixirr International plc will pay an earnout/contingent payment of $24 million cash and of $8 million common equity. A further deferred performance-based payment of up to $36 million, payable over three years (2026, 2027 and 2028) in three instalments, either in cash or through the allotment and issue of further new Ordinary Shares. As part of consideration, $125 million is paid towards common equity of TRC Advisory. Elixirr has agreed the option of a US$20.25 million Loan and an increase in its Facility with NatWest from £45 million to £65 million. For the period ending December 31, 2024, TRC Advisory reported total revenue of $28.8 million and EBITDA of $13.5 million. Tim Romberger (Founder & Managing Director), Cyrus Patel (Managing Director), Mark Skoskiewicz (Director), Garan Geist (Director), Mason Kissell (Managing Director) and Hemal Vyas (Director) will, following Completion, become Partners in Elixirr. Employee retention has been considered as part of the consideration structure for the Acquisition in order to mitigate this risk. Elixirr International plc (LSE:ELIX) completed the acquisition of TRC Advisory on September 19, 2025.
お知らせ • Jul 14Elixirr International plc to Report First Half, 2025 Results on Sep 22, 2025Elixirr International plc announced that they will report first half, 2025 results on Sep 22, 2025
お知らせ • May 30Elixirr International plc, Annual General Meeting, Jun 24, 2025Elixirr International plc, Annual General Meeting, Jun 24, 2025. Location: lainston house, woodman lane, sparsholt, winchester, so21 2lt, United Kingdom
お知らせ • Mar 11Elixirr International plc to Report Fiscal Year 2024 Results on Apr 28, 2025Elixirr International plc announced that they will report fiscal year 2024 results at 8:00 AM, GMT Standard Time on Apr 28, 2025
お知らせ • Feb 18Elixirr International plc Provides Earnings Guidance for the Financial Year Ended 31 December 2024Elixirr International plc provided earnings guidance for the financial year ended 31 December 2024. For the year, the company results are expected to be above market expectations with: Revenue greater than £111 million, above the guidance range of £108 million to £111 million.
お知らせ • Dec 20Elixirr International plc Declares Interim Dividend for the Year Ending 31 December 2024, Payable on January 24, 2025The Board of Elixirr International plc confirmed the amount and timing of its interim dividend for the year ending 31 December 2024. In accordance with the Company's dividend policy announced on 8 January 2024, the Company will continue to declare two dividends per year, with an interim dividend paid after the end of the year and a final dividend payable in August. The Company is declaring an interim dividend of 6.3 pence per Ordinary Share. The Dividend will be payable to Shareholders on the register as at 24 January 2025 and has an associated ex-dividend date of 23 January 2025. The Dividend of approximately £3.0 million in total will be paid to Shareholders on 17 February 2025 and funded from the Company's operating cash flow.
お知らせ • Dec 11Elixirr International plc Announces Changes to Chief Financial Officer, with Effect from 1 January 2025Elixirr International plc announced that Graham Busby, Co-Founder & Chief Financial Officer, will be appointed as Deputy Chief Executive Officer of Elixirr with effect from 1 January 2025. In this role, Graham will continue to be responsible for the Group's acquisition strategy which he has led since 2020. Nick Willott, Finance Director and Company Secretary, will be appointed as Chief Financial Officer with effect from 1 January 2025 and is expected to join the Board of Elixirr following completion of requisite due diligence procedures.
お知らせ • Dec 10Elixirr International plc Announces Management ChangesElixirr International plc announced the following changes to its Board of Directors. Graham Busby, Co-Founder & Chief Financial Officer, will be appointed as Deputy Chief Executive Officer of Elixirr with effect from 1 January 2025. In this role, Graham will continue to be responsible for the Group's acquisition strategy which he has led since 2020. Stephen Newton will continue as Chief Executive Officer. The Company also announces that Ian Ferguson, Co-Founder & Director, will step down from the Board on 1 January 2025, becoming a Board Advisor.
お知らせ • Oct 26+ 1 more updateElixirr International plc has completed a Follow-on Equity Offering in the amount of £24.999995 million.Elixirr International plc has completed a Follow-on Equity Offering in the amount of £24.999995 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 3,846,153 Price\Range: £6.5 Transaction Features: Subsequent Direct Listing
お知らせ • Sep 23Elixirr International plc Reiterates Earnings Guidance for the Year 2024Elixirr International plc reiterated earnings guidance for the year 2024. For the year, the company expects revenue within the guidance range of £104 million -110 million and profitability remains strong.
お知らせ • Jun 02Elixirr International plc, Annual General Meeting, Jun 25, 2024Elixirr International plc, Annual General Meeting, Jun 25, 2024. Location: lainston house, woodman lane, sparsholt, winchester so21 2lt, United Kingdom
お知らせ • Apr 24+ 1 more updateElixirr International plc Provides Earnings Guidance for the Year 2024Elixirr International plc provided earnings guidance for the year 2024. The company expects this momentum to continue over the rest of the year and, therefore, are targeting year 2024 revenue in the range of £104 million - £110 million.
お知らせ • Apr 08Elixirr International plc to Report Fiscal Year 2023 Results on Apr 22, 2024Elixirr International plc announced that they will report fiscal year 2023 results on Apr 22, 2024
お知らせ • Jan 08+ 1 more updateElixirr International plc Provides Earnings Guidance for the Year Ended 31 December 2023Elixirr International plc provided earnings guidance for the year ended 31 December 2023. Subject to audit, FY23 results are expected to be in line with market expectations with: Revenue within the guidance range of £85 million - £90 million.
お知らせ • Dec 12Elixirr International plc (AIM:ELIX) acquired Insigniam $18.5 million.Elixirr International plc (AIM:ELIX) acquired Insigniam for $18.5 million on December 11, 2023. As part of the acquisition, Elixirr welcomes four new partners into the team: Insigniam Founding Partners Shideh Bina and Nathan Rosenberg, as well as Katerin Le Folcalvez and Jennifer Zimmer. Elixirr International plc (AIM:ELIX) completed the acquisition of Insigniam on December 11, 2023.
お知らせ • Sep 19+ 1 more updateElixirr International plc (AIM:ELIX) acquired Responsum, Inc. for $6.6 million.Elixirr International plc (AIM:ELIX) acquired Responsum, Inc. for $6.6 million on September 18, 2023. The consideration consists of Potential earn-out payments of up to $1.0 million in cash and consideration of $3.4 million to be settled through the issue in September 2023 of 505,196 Elixirr International plc Ordinary shares. The Ordinary Shares purchased pursuant to the Acquisition will be subject to restrictions on sale for a total period of up to 4 years. The sellers have also agreed 3-year restrictive covenants. Responsum was co-founded by Steve Steinberg (CEO) and Adam Hofmann (Chief Marketing Officer). Steve will continue to lead the business following the Acquisition. Elixirr International plc (AIM:ELIX) completed the acquisition of Responsum, Inc. on September 18, 2023.
お知らせ • May 19+ 1 more updateElixirr International plc, Annual General Meeting, Jun 13, 2023Elixirr International plc, Annual General Meeting, Jun 13, 2023, at 08:00 Coordinated Universal Time. Location: 00 Cheapside, EC2V 6DT London United Kingdom